Tom Revell looks at a new firm hoping to make waves in the global pharmaceuticals world. The pharmaceuticals sector is a colossal industry of astronomical profits and...
US drugs giant Pfizer has withdrawn its attempt to takeover British firm AstraZeneca after having its final offer rejected. The company will now have to wait...
Blue & Green Daily finds and summarises the top sustainability stories around the web every morning. We start with our own picks from Blue & Green...
Blue & Green Daily finds and summarises the top sustainability stories around the web every morning. We start with our own picks from Blue & Green...
British drug company AstaZeneca has rejected US firm Pfizer’s final takeover proposal. Pfizer made a new offer of £55 a share, valuing the company at £69...
As Pfizer is being probed by MPs about its proposed takeover of British drugs firm AstraZeneca, reports suggest that the US pharmaceutical giant plans to make...
Blue & Green Daily finds and summarises the top sustainability stories around the web every morning. We start with our own picks from Blue & Green...
British drug company AstraZeneca has rejected a second takeover bid from US firm Pfizer, saying that the new offer still “substantially undervalued” the company. Pfizer offered...
Ethical campaigners have criticised the Church in Wales for investing millions into four controversial pharmaceutical companies, prompting the Church to defend its ‘solid ethical investment policy’....
Former Goldman Sachs director Greg Smith has given his first interview after writing a damning article in the New York Times in March about the “toxic...